Skip to Content
Merck

Clofazimine: a review of its medical uses and mechanisms of action.

Journal of the American Academy of Dermatology (1995-02-01)
J L Arbiser, S L Moschella
ABSTRACT

Clofazimine has been in clinical use for almost 40 years, but little is known of its mechanism of action. The primary indication for clofazimine is multibacillary leprosy, but it is useful in several infectious and noninfectious diseases, such as typical myocobacterial infections, rhinoscleroma, pyoderma gangrenosum, necrobiosis lipoidica, severe acne, pustular psoriasis, and discoid lupus erythematosus. Postulated mechanisms of action include intercalation of clofazimine with bacterial DNA and increasing levels of cellular phospholipase A2. Clinical experience, possible mechanisms of action, and side effects of clofazimine are summarized.

MATERIALS
Product Number
Brand
Product Description

Clofazimine for system suitability, European Pharmacopoeia (EP) Reference Standard
Clofazimine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Clofazimine